Support

Lorem ipsum dolor sit amet:

24h / 365days

We offer support for our customers

Mon - Fri 8:00am - 5:00pm (GMT +1)

Get in touch

Cybersteel Inc.
376-293 City Road, Suite 600
San Francisco, CA 94102

Have any questions?
+44 1234 567 890

Drop us a line
info@yourdomain.com

About us

Lorem ipsum dolor sit amet, consectetuer adipiscing elit.

Aenean commodo ligula eget dolor. Aenean massa. Cum sociis natoque penatibus et magnis dis parturient montes, nascetur ridiculus mus. Donec quam felis, ultricies nec.

Have any Questions? +49 33 767 - 791 10

Seramun News

Biotechnology company in Heidesee inaugurates its new production building under the patronage of the former Federal Minister of Economics Brigitte Zypries

Heidesee, 17.09.2021

The biotechnology company Seramun Diagnostica GmbH officially inaugurates its new production building at its location in Heidesee, Germany today under the patronage of the former Federal Minister of Economics and Justice Brigitte Zypries.  

The new production building is another milestone in the company’s successful, almost 30-year history. The investment sum of 10 million euros was largely financed from the companies’ own resources - around one million euros was contributed by the business promotion bank of the federal state of Brandenburg. In addition to state-of-the-art production areas and quality control laboratories, cold stores, warehouses as well as offices and documentation areas have been created. The invited guests of the inauguration ceremony have the unique opportunity to view
parts of the completed production areas in guided tours before the official start of production. Management and shareholders are available for questions and photos after the opening ceremony at the champagne reception.

SARS-CoV-2 RBD IgG

ADDITIONAL RESULTS OF SARS-CoV-2 VACCINE STUDY

Why it is important to continue to maintain non-pharmaceutical protective measures even with a high vaccination rate in Germany and why a 3rd booster vaccination might be necessary for older people.An indication of this is shown by the following study in which our product SeraSpot® Anti-SARS-CoV-2 IgG was used.

Schwarz, T., et al., Delayed Antibody and T-Cell Response to BNT162b2 Vaccination in the Elderly, Germany. Emerg Infect Dis, 2021. 27(8).

https://wwwnc.cdc.gov/eid/article/27/8/21-1145_article

Would you like to know more, look at the study or contact us mathias.schlegel@seramun.com.

© Copyright 2001 - 2021   Seramun Diagnostica GmbH. All Rights Reserved.